Cipla (CPLFY) OCF Margin %: 0.00% (As of Mar. 2026)


What is Cipla OCF Margin %?

Cipla CPLFY 94 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates CPLFY with a GF Score™ of 94/100. The stock has 3 warning signs investors should review. Among 959 Drug Manufacturers companies, Cipla ranks better than 63.4% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cipla's Cash Flow from Operations for the three months ended in Mar. 2026 was $0.00 Mil. Cipla's Revenue for the three months ended in Mar. 2026 was $696.44 Mil. Therefore, Cipla's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Cipla's current OCF Yield % is 3.60%.

The historical rank and industry rank for Cipla's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Cipla was 19.78%. The lowest was 9.96%. And the median was 15.82%.

CPLFY's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.95
* Ranked among companies with meaningful OCF Margin % only.

Cipla OCF Margin % Related Terms

Cipla OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cipla's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cipla OCF Margin % Chart

Cipla Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.38 14.41 16.25 18.44 14.22

Cipla Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cipla OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cipla's OCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=424.488/2985.588
=14.22 %

Cipla's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/696.443
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Cipla (CPLFY) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cipla and its competitors. Over the past decade, Cipla's OCF Margin % has ranged from 9.96 to 19.78. According to the industry distribution chart, Cipla ranks #351 out of 959 companies in the Drug Manufacturers industry, placing it in the top 36.6%.
Is Cipla's OCF Margin % too high?
Cipla's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 9.96 to a high of 19.78. Based on the distribution chart, Cipla ranks #351 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Cipla has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Cipla's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Cipla ranks #351 out of 959 companies for OCF Margin %. This puts Cipla in the upper half of its industry. The industry median OCF Margin % is 9.95. Historically, Cipla's own OCF Margin % has ranged from 9.96 to 19.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cipla and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cipla's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipla stock overvalued right now?
Cipla (CPLFY) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Cipla's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cipla (CPLFY), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cipla Business Description

Other Exchanges CIPLA:India500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.